Recent advances in treating female genital human papillomavirus related neoplasms with topical imiquimod

F Borella, N Gallio, L Mangherini… - Journal of Medical …, 2023 - Wiley Online Library
Human papillomavirus (HPV) encompasses a group of viruses that infect the skin and
mucous membranes. In the presence of certain factors, persistent infection with high‐risk …

Imiquimod is effective in reducing cervical intraepithelial neoplasia: a systematic review and meta-analysis

B Hamar, B Teutsch, E Hoffmann, P Hegyi, A Harnos… - Cancers, 2024 - mdpi.com
Simple Summary There are publications on the use of Imiquimod in cervical intraepithelial
neoplasia (CIN) and HPV clearance; however, the literature is not consistent about its …

The efficacy of topical imiquimod in high‐grade cervical intraepithelial neoplasia: a systematic review and meta‐analysis

AJM Van De Sande, M Kengsakul… - … of Gynecology & …, 2024 - Wiley Online Library
Objective A major side effect of cervical excision for high‐grade cervical intraepithelial
neoplasia (CIN) is premature birth. A non‐invasive treatment for reproductive age women is …

Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC‐2): A randomised controlled trial

AJM van de Sande, R van Baars… - … Journal of Obstetrics …, 2024 - Wiley Online Library
Objective To investigate the efficacy of imiquimod in women with residual or recurrent
cervical intraepithelial neoplasia (rrCIN), compared with large loop excision of the …

Modulation of sHLA-G, PD-1, and PD-L1 Expression in Cervical Lesions Following Imiquimod Treatment and Its Association with Treatment Success

A Cokan, NCH da Silva, R Kavalar, I But, M Pakiž… - Cancers, 2024 - mdpi.com
Simple Summary This study investigates the therapeutic potential of imiquimod (IMQ), a
synthetic toll-like receptor 7 agonist, for treating cervical intraepithelial neoplasia (CIN) …

[PDF][PDF] Het belang van preventie en tijdige behandeling van CIN en cervixcarcinomen

NE Simons, MA Lugthart - Met onder andere - nvog.nl
249 wordt daardoor effectiever en kostenefficiënter. In de VACCIN-studie zijn inmiddels ruim
achthonderd vrouwen geïncludeerd en de onderzoekers wachten nu op de resultaten. De …